Pinnacle Completes Purchase of South Texas Research Institute with Focus on NASH

Pinnacle Clinical Research, part of the LongueVue Capital portfolio, completed its acquisition of the South Texas Research Institute, which is known for its clinical research of nonalcoholic steatohepatitis (NASH).